Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. financial statements

Entrada Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 25.42M10-K
Net income−USD 143.75M10-K
Cash and equivalentsUSD 90.39M10-Q
Total debtUSD 50.93MEODHD

Entrada Therapeutics, Inc. financials on 6ix · Entrada Therapeutics, Inc. on 6ix